Aurinia Pharmaceuticals Inc
F:IKAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aurinia Pharmaceuticals Inc
F:IKAP
|
CA |
|
Anterix Inc
NASDAQ:ATEX
|
US |
|
Flutter Entertainment PLC
NYSE:FLUT
|
IE |
Multiples-Based Value
The Multiples-Based Value for
Aurinia Pharmaceuticals Inc (IKAP) under the Base Case is 7.708 EUR.
Compared with the current market price of 13.075 EUR, the stock appears
Overvalued by 41% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.